Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation.docVIP

Pharmaceuticals 2012, 5, 155-168; doi:10.3390/ph5020155 OPEN ACCESS Pharmaceuticals ISSN 1424-8247 /journal/pharmaceuticals Review Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation Claudia St?llberger 1,* and Josef Finsterer 1,2 1 Krankenanstalt Rudolfstiftung, Second Medical Department, Juchgasse 25, Wien A-1030, Austria 2 Danube University Krems, Doktor-Karl-Dorrek-Stra?e 30, Krems A-3500, Austria; E-Mail: josef.finsterer@wienkav.at * Author to whom correspondence should be addressed; E-Mail: claudia.stoellberger@chello.at; Tel.: +43-1-945-4291; Fax